ALK+ and ALK- ALCL combined represent ~2% of all adult non-Hodgkin lymphomas and are the fourth most common TCL (~10%) after peripheral TCL, not otherwise specified (PTCL, NOS), mycoses fungoides, and angioimmunoblastic TCL [11,12]. This evidence concerns the gene ALK and mature T-cell and NK-cell non-Hodgkin lymphoma.